Disclosures for "Cerebral Failure Is the Most Common Mode of Death in Adults with Primary Brain Tumors "
-
Miss reda has nothing to disclose.
-
Dr. Lyons has nothing to disclose.
-
Ms. Yen has nothing to disclose.
-
Dr. McMullen has nothing to disclose.
-
Dr. Clarke has nothing to disclose.
-
Dr. Leung has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Leung has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Curio.
-
Dr. Franson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Inc. Dr. Franson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Franson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Franson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kissane Associates. The institution of Dr. Franson has received research support from Regeneron. The institution of Dr. Franson has received research support from Day One Biotherapeutics. The institution of Dr. Franson has received research support from Springworks Therapeutics.
-
Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Junck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier Pharmaceuticals, LLC. Dr. Junck has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bowman & Brooke.